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There havebeen attempts to couple bile acids to fluorescein to permit their visu-
alization during studies ofphysiology and pathophysiology. Although conjuga-
tion has been achieved by many, the product differed in many respects from the
parent bile acid congener. We describe lysylfluorescein conjugated bile acid
analogues (LFCBAA) synthesized in our laboratory as model divalent "unipo-
lar" molecules. We have determined LFCBAA properties including their
water:octanol partition coefficient, HPLC retention time and critical micellar
concentration and compared them with their parent bile acid congeners. Cholyl
lysylfluorescein (CLF) and lithocholyl lysylfluoroscein (LLF ) have properties
similar to cholylglycine (CG) and glycolithocholate (GLC), respectively. In
human and rat hepatocytes uptake of CLF follows Michaelis-Menten kinetics
with Km andVm similar to CG. Biliary excretion rates ofCLF and LLF close-
ly resemble those of CG and GLC in both normal and mutant TR- rats which
lack the multiorganic anion transporter (MOAT), strongly supporting the notion
that CLF and LLF are substrates for the canalicular bile salt transporter (cBST).
The close similarity of hepatocyte uptake and biliary secretion of these
LFCBAA and their parent bile acid congeners makes them potentially useful
probes for the intracellular visualization ofbile salt movement and deposition in
various models ofbile formation and secretion.
INTRODUCTION
Bile salts are amphiphilic acidic steroids with detergent properties [1]. Their tran-
scellular transport in the liver and subsequent canalicular secretion is associated with their
unique physicochemical properties determined by the interplay ofthe effects of the num-
ber and orientations of the steroid ring hydroxyl groups [2], side chain length and charge
[3], as well as any conjugate or charged species on the steroid ring [4]. These numerous
structural variations contribute to the hydrophilic-hydrophobic balance of each bile salt
molecule [5]. A good indication of this balance can be obtained from their relative reten-
tion times on high performance liquid chromatography (HPLC)b or water:octanol parti-
tion coefficient (WOPC), which represents the probable distribution of a bile salt mole-
cule between membranes and the aqueous milieu [6]. Any fluorescent bile salt analogue
synthesized should have this amphiphilic property and incorporate at least one negative
a To whom all correspondence should be addressed: Dr. C.O. Mills, Liver and Hepatobiliary Unit,
Liver Research Laboratories, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK.
Fax: 144-121-627-2449.
bAbbreviations: LFCBAA, lysylfluorescein conjugated bile acid analogues; HPLC tr, high perfor-
mance liquid chromatography retention time; CG, cholylglycine; CLF, cholyl lysylfluorescein; LLF,
lithocholyl lysylfluorescein; CMC, critical micellar concentration, GLC, glycolithocholate; MOAT,
multiorganic anion transporter; cBST, canalicular bile salt transporter; WOPC, water-octanol parti-
tion coefficient; FITC-CG, fluorescein isothiocyanate-glycocholate; Ntcp, Na+ taurocholate-cotrans-
porting polypeptide; Oatpl, organic anion transporting polypeptide; TC, taurocholate; CDCLF,
chenodeoxycholyl lysylfluorescein; IPRL, isolated perfused rat liver; CVA, canalicular vacuole
accumulation; NBD, 70-nitroazooxadiol.
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charge on the side chain to make it unipolar [7]. The hydrophilic-hydrophobic balance
mustbe similarto that ofnatural bile salts because eachmolecule's physicochemical prop-
erties so precisely determines its biological properties. Previous attempts to produce flu-
orescein conjugates of bile salts, which preserve these essential bile salt characteristics,
have been only partially successful. These include fluorescein isothiocyanate-glyco-
cholate (FITC-CG) employed by Kitamura et al. [8] and the fluorescent bile acid ana-
logues based on 71-nitroazooxadiol (NBD) [9, 10]. The chemical structures of different
fluorescent bile acid analogues are shown in Figure 1. In this communication, we report
on the physical and biological properties of cholyl lysylfluorescein (CLF) and related
lysylfluorescein conjugated bile acid analogues (LFCBAA) synthesized in our laboratory
by C.O. Mills [11]. We report for the first time the results ofuptake experiments for CLF
in human hepatocytes and review other recently published data pertaining to LFCBAA.
Fluorescein Conjugates
of Bile Acids
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Figure 1. Chemical structures of glycolithocholic acid and various fluorescent bile salts.
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Table 1. Physicochemical properties ofLFCBAA.
Bile salt WOPC (molar ratio) HPLC tr (min) CMC (mM)
[14C]-CG ND 8.492 6.5
CLF ND 8.775 6.5
[14C]-GLC 3.5±0Q5* 26.617* 2.9*
LLF 6.5±2.2* 27.950* 3.8*
Abbreviations: ND, not done; HPLC tr, high performance liquid chromatography retention time;
[14C]-CG, carbon -14 cholylglycine; CLF, cholyl lysylfluorescein; LLF, lithocholyl lysylfluores-
cein; CMC, critical micellar concentration, [14C]-GLC, carbon-14glycolithocholate; WOPC, water-
octanol partition coefficient. * Ref. [12].
PHYSICAL PROPERTIES OF LYSYL FLUORESCEIN
CONJUGATED BILEACID ANALOGUES
Lysyl fluorescein bile acid analogues are freely soluble in water. They represent the
analogues of glycine conjugates ofbile salts with the least soluble, lithocholyl lysyl fluo-
rescein (LLF) having a water:octanol partition coefficient, similar to glycolithocholate
[12]. LFCBAA synthesized in our laboratory also share similar hydrophobic-hydrophilic
balance with their respective natural congeners asjudged by their relative HPLC retention
times (Rt) (Table 1).
Another physical characteristic of bile salts is their tendency to form polymolecular
aggregates or micelles in water when present at concentrations above their critical micel-
lar concentration (CMC). Using the Du Nouy ring detachment method [13, 14] and the
dye solubilization measurement as described by Roda et al. [2], we found the CMC of
CLF and LLF to be similar to cholylglycine (CG) and glycolithocholate (GLC) respec-
tively (Table 1).
The similarity between the physical characteristics of each lysylfluorescein bile salt
analogue and its natural congener with respect to their partition coefficients and HPLC
retention times suggests that attachment of the fluorophore within LFCBAA has a minor
effect on the physico-chemical properties which characterize bile salts.
BIOLOGICAL PROPERTIES OF LFCBAA
Several studies have shown that bile salts such as taurocholate and glycocholate are
transported within the liver by ATP dependent transporter systems at the sinusoidal (or
basolateral) and canalicular plasma membrane domains ofhepatocytes [15-18].
Theirbasolateral uptake is mediated by Na+ taurocholate-cotransporting polypeptide
(Ntcp), which is a 51 kDa glycoprotein, selectively localized to the sinusoidal membrane
[19, 20]. A second transporter system, multispecific and Na+ independent is mediated by
a 80 kDa protein called organic anion transporting polypeptide (Oatpl) [21, 22] and is
responsible for the transport ofunconjugated bile acids as well as many other, different-
ly charged substrates including anionic steroid conjugates or even some amphipathic
organic cations [21, 23, 24]. At the canalicular membrane the liver secretes into bile a
variety of organic anions besides hydrophilic bile salts. These include fluorescent dyes,
glucuronide conjugates ofbilirubin and sulfate and glucuronide conjugates ofhydropho-
bic bile salts like lithocholate [25]. These anions are secreted via an ATP-dependent
mechanism different from that which secretes hydrophilic bile salts. The mediator ofthis
transport mechanisms is called multi-specific organic anion transporter (MOAT). A
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hereditary defect in MOATprobably accounts for the conjugated hyperbilirubinemia pre-
sent in the human Dubin-Johnson syndrome as well as in mutant TR- rats, the equivalent
animal model [26].
The following subsections will report for the first time uptake, transcellular transport
and biliary secretion ofLFCBAA in vitro and in vivo studies.
Uptake ofLFCBAA into human hepatocytes in vitro
The relative uptake kinetics of CLF and CG were studied in human hepatocytes iso-
lated from tissue leftover after trimming donor livers utilized in "reduced-size" transplan-
tation in pediatric recipients [27]. Viability ofhepatocyte preparations ranged between 95
and 99 percent by Trypan blue exclusion [28]. Hepatocytes were incubated with 5 to 200
gM solutions of either CLF or [14C] - CG at different time intervals (15 sec-30 min) at
37°C in Krebs-Hensleit buffer and uptake ofCLF was measured by a Perkin-Elmer LS 5B
fluorimeter and [14C]-CG by liquid scintillation counter.
Results were taken as the mean of triplicate readings using isolates from 4 donor
organs. Velocity ofinitial uptake (V) was calculated from the slope ofuptake versus time
curve at each concentration (Figures 2A and B). The Michaelis Menten constant(Km) and
maximum velocity (Vmax) were then calculated from intercepts of Lineweaver-Burke
plots (Figure 2C). Uptake of both CLF and [14C]-CG was similar, (Km, 37.8 ± 13.1 ,uM
and 30 ± 5.8 ,uM, respectively) as was the maximal transport velocity (Vmax 11.8 ± 1.2
and 16.1 ± 6.4 FM/106 cells/min, respectively). Co-incubation of CLF with [14C]-CG at
20 ,uM and 40 ,uM concentration, respectively, resulted in 87 percent inhibition ofuptake
(Figure 3). These uptake kinetics ofCLF and CG suggest that they share a common sinu-
soidal transport mechanism and may be competing ligands for the Ntcp transporter. This
demonstration of competitive inhibition of hepatocyte uptake may also explain the pub-
lished observation ofreduced canalicular vacuole accumulation ofCLF when hepatocyte
couplets were incubated in the presence of both taurocholate (TC) with CLF [29, 30].
The external sodium chloride employed in the uptake kinetic study of CLF and CG
was at physiological concentration (0.15 M) to reflect the sodium dependence of Ntcp
[31], and it would be anticipated that like TC decrease in the extracellular sodium chlo-
ride concentration would impair the uptake of CLF and other LFCBAA for Ntcp on the
basolateral plasma membrane ofhepatocytes.
Transcellular transport ofLFCBAA
The transcellular route by which bile salts proceed from portal blood to bile has been
investigated in a series of collaborative experiments. Using CLF and chenodeoxycholyl
lysylfluorescein (CDCLF), it was shown that thepartitioning ofthese fluorescent bile acid
analogues into intracellular compartments, and their canalicular secretion proceeds as
simultaneous rather than sequential process [30]. In a further series of experiments
employing LFCBAA, there is preliminary evidence that choleretic (CLF, CDCLF) and
cholestatic (LLF) bile salts follow different transcellular pathways as CLF and CDCLF
moved rapidly through the cytoplasm, unaffected by microtubular inhibition [30, 32]. On
the other hand, plasma-bile transport of LLF and ursodeoxycholyl lysyl fluorescein was
significantly delayed by colchicine treatment indicating that these bile acids were proba-
bly involved in a microtubule dependent vesicular system of transport within the hepato-
cyte [32]. The results indicate that LFCBAA can serve as probes in the study of hepatic
transcellular transport and may shed light on unresolved mechanisms by which ligand
trafficking is effected, involving cytosolic proteins, intracellular membranes and/or
tubulovesicular movement.
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Figure 2A. Mean uptake vs time plot for cholyl lysyl fluorescein (CLF). normal human hepato-
cytes isolated from human liver (n = 4) by a modified collagenase perfusion technique was resus-
pended in Kreb's-Hensleit buffer. Cells with a viability between 92-97 percent (by trypan blue
exclusion) were used. Cells were incubated at 37°C with shaking at 60 oscillations/min for 15-90
sec, at concentrations of 5,10, 20, 50 100 or 200 gM. Uptake fluorescence of CLF was measured
with a Perkin-Elmer LS 5B fluorimeter. Only plots up to a concentration of 20 gM are shown.
Concentration of 5 IM (*), 10 jM (U) and 20 jM (A). Each point represents the mean of4 exper-
iments in which each analysis was performed in triplicate.
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Figure 2B. Mean uptake vs Time plot for [14C]-cholyl-glycine ([14C1-CG). Normal human liver
leftover after "cutdowns" used for [ 4C]-CG, n = 3. The procedure for [ 4C]-CG was similar to that
of CLF in figure 2A except that measurement of [14C]-CG radioactivity was by Beckman liquid
scintillation counter. Concentration of 5 ,uM (*), 10 jM (U) and 20 jM (A).
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Figure 2C. Lineweaver-Burke plot for CLF (0) and [14CJ-CG (U): Velocity ofinitial uptake (V)
for CLF and [14C]-CG was calculated from slope ofuptake vs time (Figures 2A and 2B respective-
ly) curves at each concentration. Michaelis-Menten Km and maximum velocity, Vm were calculated
from intercepts ofLineweaver-Burke plot (1/V vs 1/S) for CLF and [14C]-CG.
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Figure 3. Inhibition study: Human liver leftover after "cutdowns" was processed as described
under figure 2A. Hepatocytes with a viability between 92-97 percent (by trypan blue exclusion)
were incubated with both CLF (closed symbols) and [14C]-CG (open symbols) at 20 and 40 ,uM
concentrations respectively (n = 5) gave 90 percent inhibition of CLF uptake at all the time points
investigated between 15-90 sec.
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Table 2. Biliary output oflipids and bile salt recovery.
Bile salt Cholesterol/bile acid Phospholipid/bile acid Cum. excr. in bile
(0-20 percent) of dose.
[14C]-CG 0.019* 0.30* 93.1 ± 1.2t
CLF 0.20* 0.27* 94.4± 0.3t
Abbreviations: [14C]-CG, carbon-14 cholylglycine, CLF, cholyl lysylfluorescein, cum. excr., cum-
mulative excretion. *Ref. [34]. tRef. [11].
Biliary secretion ofLFCBAA
Bile formation is a highly regulated process [15] involving the canalicular transporter
proteins including MOAT and cBST, which represent the molecular basis of bile salt-
dependent bile flow [33] and are responsible for biliary clearance of unipolar bile salts.
Following bolus intravenous injection in the bile-fistula rat model and in the isolated per-
fused rat liver (IPRL) model, biliary clearance of CLF was similar to that of [14C]-CG
with near complete excretion of the unchanged molecule occurring within 20 min [11].
During their investigation ofbile salt interaction with lipids, Baxter et al. [34] found that
at high infusion rates that exceeded the normal flux of bile salt through the liver in rats,
CLF was transferred to bile less efficiently than glycocholate but that, within the bile, the
ratio ofcholesterol:bile acid or phospholipid:bile acid was not different for CLF and CG
in the IPRL model (Table 2). In experiments with rat hepatocyte couplets, CLF canalicu-
lar vacuole accumulation was rapid with optimum canalicular vacuole accumulation
observed within 1-2 min [35] and contrasted sharply with the finding of slow canalicular
secretion of carboxy dichloro-fluorescein diacetate (CFDA), which is a MOAT substrate
[36]. A further series of experiments were reported in control and mutant TR- rats that
lack a functional multispecific organic anion transporter MOAT/mrp2 [37]. We found the
secretion of CLF (65 percent in 30 min) [38] in mutant TR- rats to be similar to cheno-
deoxycholyl taurine (67 percent in 30 min) reported previously [4] suggesting that CLF
utilizes the bile salt transporter which is responsible for ATP dependent secretion of bile
salts [19, 39-41], thus further confirming its biological functionality as that of a divalent
fluorescent unipolar bile salt analogue.
On the basis ofthese systematic studies LFCBAA appear to have a significant poten-
tial application to studies of hepatocyte function and dysfunction.Thus CLF retention is
used as a marker of integrity of canaliculi between hepatocyte couplets [32]. Couplet
canalicular accumulation ofCLF may be a sensitive indicator ofbile canalicular secretion
and canalicular vacuole accumulation (CVA) within the sealed canalicular space, formed
by hepatocyte couplets has been utilized as a sensitive indicator ofcanalicular dysfunction
and cholestasis in studies with menadione and cyclosporin [42-44] as recently reviewed
by Coleman et al. [45].
POSSIBLE APPLICATIONS OF LFCBAA
Plasma clearance studies
In preliminary studies involving six healthy human volunteers, the plasma clearance
ofCLF appeared to obey a three exponential model ofelimination [46], similar to that of
14C-glycocholic acid as described previously by Engelking et al. [47].
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Halflives for the first, second and third phase were 1.7 ± 0.9 min, 6.7 ± 1.6 min and
68 ± 17 min, respectively [46], as compared to biexponential values of 1.7 ± 0.1 and 7.0
± 0.3 min forradiolabelled cholylglycine found by others [48]. The volume ofdistribution
ofCLF and plasma retention expressed as residual fluorescence after 60 min were similar
to the data obtained by others for conventional or radiolabelled bile acids [49, 50].
This study showed that, in normal human subjects, CLF clearance is similar to the
clearance ofnatural bile acids and may potentially offer a new, dynamic test ofliver func-
tion.
In vivo visualization ofthe biliary tree.
We have conducted preliminary studies to evaluate application of CLF for intraoper-
ative visualization ofthe biliary tree. In rabbits [51], we found that within 2 min of a sin-
gle intravenous injection ofCLF, the entire extrahepatic biliary tree and gallbladder ofthe
rabbit became brightly fluorescent when viewed under Woods' light. Excellent visualiza-
tion persisted for up to 45 min. Iatrogenic bile leaks could be seen and located with ease.
Further developmental work is required to determine whether this technique could be
applied for intraoperative visualization ofthe biliary tree in humans.
Limitations ofLFCBAA
Intensity offluorescence decreases forLFCBAA in acidic solution whereas the inten-
sity increases in alkaline solution. Therefore, fluorescent bile salts are dissolved in
buffered solutions (pH 7.4) [11] to overcome the pH-dependent variability in fluorescence
measurement. Because of this pH dependence of the fluorescence quantum yield of
LFCBAA no direct quantitative assumptions regarding concentrations ofLFCBAA should
be based on the intensity of in vivo fluorescence. Protein binding of LFCBAA, such as
binding of CLF or CDCLF to albumin, also decreased fluorescence intensity [30].
Because of these constraints, in the CLF serum clearance study [46] CLF was extracted
from serum by using methanol to precipitate serum proteins followed by measurement of
fluorescence of CLF in the supernantant.
Despite the need for cautious interpretation of the experimental findings, the numer-
ous studies carried out with CLF and other LFCBAA in a variety ofexperimental models
including hepatocyte couplets, isolated perfused livers or mutant TR- rats have provided
information on their hepatocellular deposition, as well as the plasma and biliary kinetics
ofbile salt transport.
CONCLUSION
Further studies are required to define the role and limitations ofLFCBAA as probes
of bile salt transport in health and disease. On the basis of our early studies, we believe
they have apotentially useful role as long as their properties and movement can be shown
to be consistent with those of their naturally occurring bile salt congeners. The similar
physical and biological properties of CLF to that of CG justify its utilization in bile acid
transport studies [32, 34, 35, 42-44, 52].
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